Skip to search formSkip to main contentSkip to account menu

T 0632

Known as: T-0632 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Development of a Highly Selective Allosteric Antagonist Radioligand for the Type 1 Cholecystokinin Receptor and Elucidation of Its Molecular Basis of Binding
Understanding the molecular basis of ligand binding to receptors provides insights useful for rational drug design. This work… 
2014
2014
Investigation of Reductive Amination in the Synthesis of T-0632
2 
2014
2014
Preparation of Analogs of the GLP-1 Receptor Inverse Agonist, T-0632
4 
Highly Cited
2001
Highly Cited
2001
A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.
The glucagon-like peptide 1 receptor (GLP-1R) belongs to a distinct subgroup of G protein-coupled peptide hormone receptors… 
1997
1997
Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Effects of a new cholecystokinin (CCK)A-receptor antagonist, T-0632 [sodium (S)-1-(2-fluorophenyl)-2, 3-dihydro-3-[(3… 
1996
1996
Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
1996
1996
Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)